CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 72 enrolled
Drug / intervention
Glycopyrronium cloth, 2.4% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03880266
NCT03880266Phase 2Completed
CompareCT.gov

A Phase 2, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis

Journey Medical Corporation·interventional·Posted Mar 19, 2019·Updated Aug 25, 2021

In Brief

A Phase 2 clinical trial evaluating Glycopyrronium cloth, 2.4% and Vehicle for Palmar Hyperhidrosis. Completed, enrolled 72 participants across 7 sites.

Detailed Summary

The objective of this study is to assess the efficacy and safety of glycopyrronium cloth, 2.4% when used to treat palmar hyperhidrosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPalmar Hyperhidrosis
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedMar 19, 2019
Enrollment StartFeb 22, 2019
Primary CompletionMay 24, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.3 years ago

Interventions

Glycopyrronium cloth, 2.4%drug

Pre-saturated 100% polypropylene, nonwoven, fabric cloth with glycopyrronium

Vehicledrug

Pre-saturated 100% polypropylene, nonwoven, fabric cloth